American Journal of Cardiology
Volume 104, Issue 11 , Pages 1494-1498 , 1 December 2009

Impact of Clinical and Subclinical Peripheral Arterial Disease in Mid-Term Prognosis of Patients With Acute Coronary Syndrome

  • Pedro Morillas, MD, PhD

      Affiliations

    • Hospital Universitario de San Juan, Alicante, Spain
    • Corresponding Author InformationCorresponding author: Tel: 34-965-938-730; fax: 34-965-937-742
    • ,
  • Juan Quiles, MD, PhD

      Affiliations

    • Hospital Universitario de San Juan, Alicante, Spain
    • ,
  • Alberto Cordero, MD, PhD

      Affiliations

    • Hospital Universitario de San Juan, Alicante, Spain
    • ,
  • Josep Guindo, MD, PhD

      Affiliations

    • Corporació Sanitaria Parc Taulí, Sabadell, Spain
    • ,
  • Federico Soria, MD, PhD

      Affiliations

    • Hospital Virgen de la Arrixaca, Murcia, Spain
    • ,
  • Pilar Mazón, MD, PhD

      Affiliations

    • Hospital Clínico Universitario, Santiago de Compostela, A Coruña, Spain
    • ,
  • Jose Ramón Gonzalez-Juanatey, MD, PhD

      Affiliations

    • Hospital Clínico Universitario, Santiago de Compostela, A Coruña, Spain
    • ,
  • Vicente Bertomeu, MD, PhD

      Affiliations

    • Hospital Universitario de San Juan, Alicante, Spain
    • ,
  • Prevalence of Peripheral Arterial Disease in Patients With Acute Coronary Syndrome (PAMISCA) Investigators

Received 28 March 2009 ,Revised 2 July 2009 ,Accepted 2 July 2009.

References 

  1. Bertomeu V, Morillas P, Gonzalez-Juanatey JR, Quiles J, Guindo J, Soria F, et al. Prevalence and prognostic influence of peripheral artery disease in patients ≥40-years-old admitted into hospital following an acute coronary event. Eur J Vasc Endovasc Surg. 2008;36:189–196
  2. Hirsch AT, Haskal ZJ, Hertzer NR, Bakal CW, Creager MA, Halperin JL, et al. ACC/AHA 2005 practice guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA task force on practice guidelines (writing committee to develop guidelines for the management of patients with peripheral arterial disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation. Circulation. 2006;113(suppl):e463–e654
  3. Cotter G, Cannon CP, McCabe CH, Michowitz Y, Kaluski E, Charlesworth A, et al. Prior peripheral arterial disease and cerebrovascular disease are independent predictors of adverse outcome in patients with acute coronary syndromes: are we doing enough? (Results from the Orbofiban in Patients with Unstable Coronary Syndromes–Thrombolysis In Myocardial Infarction (OPUS-TIMI) 16 study). Am Heart J. 2003;145:622–627
  4. Spencer FA, Lessard D, Doubeni C, Yarzebski J, Gore JM, Goldberg RJ. Treatment practices and outcomes of patients with established peripheral arterial disease hospitalized with acute myocardial infarction in a community setting. Am Heart J. 2007;153:140–146
  5. Froehlich JB, Mukherjee D, Avezum A, Budaj A, Kline-Rogers EM, Lopez-Sendon J, et al. Association of peripheral artery disease with treatment and outcomes in acute coronary syndromes (The Global Registry of Acute Coronary Events (GRACE)). Am Heart J. 2006;151:1123–1128
  6. Murkherjee D, Eagle K, Kline-Rogers E, Feldman LJ, Juliard JM, Agnelli G, et al. Impact of prior peripheral arterial disease and stroke on outcomes of acute coronary syndromes and effect of evidence-based therapies (from the Global Registry of Acute Coronary Events). Am J Cardiol. 2007;100:1–6
  7. Chiu J, Topol E, Wittlow P, Hsu A, Tuzcu EM, Franco I, et al. Peripheral vascular disease and one-year mortality following percutaneous coronary revascularization. Am J Cardiol. 2003;92:582–583
  8. Nikolsky E, Mehran R, Dangas GD, Lasic Z, Mintz GS, Negoita M, et al. Prognostic significance of cerebrovascular and peripheral arterial disease in patients having percutaneous coronary interventions. Am J Cardiol. 2004;93:1536–1539
  9. Fowkes FG, Murray GD, Butcher I, Heald CL, Lee RJ, Chambless LE, et al. Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis. JAMA. 2008;300:197–208
  10. Diehm C, Lange S, Darius H, Pittrow D, von Stritzky B, Tepohl G, et al. Association of low ankle brachial index with high mortality in primary care. Eur Heart J. 2006;27:1743–1749
  11. Heald CL, Fowkes FG, Murray GD, Price JF. Risk of mortality and cardiovascular disease associated with the ankle-brachial index: systematic review. Atherosclerosis. 2006;189:61–69
  12. O'Hare AM, Katz R, Shlipak MG, Cushman M, Newman AB. Mortality and cardiovascular risk across the ankle-arm index spectrum: results from the Cardiovascular Health Study. Circulation. 2006;113:388–393
  13. Agnelli G, Cimminiello C, Meneghetti G, Urbinati S Polyvascular Atherothrombosis Observational Survey (PATHOS) Investigators. Low ankle-brachial index predicts an adverse 1-year outcome after acute coronary and cerebrovascular events. J Thromb Haemost. 2006;4:2599–2606
  14. Resnick HE, Lindsay RS, McDermott MM, Devereux RB, Jones KL, Fabsitz RR, et al. Relationship of high and low ankle brachial index to all-cause mortality (The Strong Heart Study). Circulation. 2004;109:733–739
  15. Ostergren J, Sleight P, Dagenais G, Danisa K, Bosch J, Qilong Y, et al. Impact of ramipril in patients with evidence clinical or subclinical peripheral arterial disease. Eur Heart J. 2004;25:17–24
  16. Aboyans V, Lacroix P, Postil A, Guilloux J, Rolle F, Cornu E, et al. Subclinical peripheral arterial disease and incompressible ankle arteries are both long-term prognostic factors in patients undergoing coronary artery bypass grafting. J Am Coll Cardiol. 2005;46:815–820
  17. Lamina C, Meisinger C, Heid IM, Lowel H, Rantner B, Koenig W, et al. Association of ankle-brachial index and plaques in the carotid and femoral arteries with cardiovascular events and total mortality in a population-based study with 13 years of follow-up. Eur Heart J. 2006;27:2580–2587
  18. Chang ST, Chen CL, Chu CM, Chung CM, Hsu JT, Cheng HW, et al. Ankle-arm index as a predictor of lesion morphology and risk classification for coronary artery disease undergoing angioplasty. Int J Cardiol. 2006;113:385–390
  19. Otah K, Madan A, Otah E, Badero O, Clark LT, Salifu MO. Usefulness of an abnormal ankle-brachial index to predict presence of coronary artery disease in African-Americans. Am J Cardiol. 2004;94:481–483
  20. Moussa ID, Jaff MR, Mehran R, Gray W, Dangas G, Lazic Z, et al. Prevalence and prediction of previously unrecognized peripheral arterial disease in patients with coronary artery disease: the Peripheral Arterial Disease in Interventional Patients Study. Catheter Cardiovasc Interv. 2009;73:719–724
  21. Murabito JM, Keyes MJ, Guo CY, Keaney FJ, Vasan RS, D'Agostino RB, et al. Cross-sectional relations of multiple inflammatory biomarkers to peripheral arterial disease: the Framingham Offspring Study. Atherosclerosis. 2009;203:509–514
  22. Huelmos A, Jimenez J, Guijarro C, Belinchon JC, Puras E, Sanchez C, et al. Underrecognized peripheral arterial disease in patients with acute coronary syndrome: prevalence of traditional and emergent cardiovascular risk factors. Rev Esp Cardiol. 2005;58:1403–1410
  23. Januzzi JL, Buros J, Cannon CP Tactics TIMI 18 Investigators. Peripheral arterial disease, acute coronary syndromes, and early invasive management: the TACTICS TIMI 18 trial. Clin Cardiol. 2005;28:238–242

 This registry was supported by an unrestricted grant from Sanofi Aventis, Barcelona, Spain.

PII: S0002-9149(09)01350-2

doi: 10.1016/j.amjcard.2009.07.014

American Journal of Cardiology
Volume 104, Issue 11 , Pages 1494-1498 , 1 December 2009

Article Tools

* Image Usage & Resolution